Sialylation-Increasing Therapies For Diseases Associated With Oxidative Stress Read more about Sialylation-Increasing Therapies For Diseases Associated With Oxidative Stress European Patent16714599.4Filed on 2016-02-23
Sialylation-Increasing Therapies For Diseases Associated With Oxidative Stress Read more about Sialylation-Increasing Therapies For Diseases Associated With Oxidative Stress Canada2979640Filed on 2016-02-23
Synthetic Methylmalonyl-CoA Mutase Transgene For The Treatment Of Mut Class Methylmalonic Acidemia (MMA) Read more about Synthetic Methylmalonyl-CoA Mutase Transgene For The Treatment Of Mut Class Methylmalonic Acidemia (MMA) US Patent 10,307,469Filed on 2017-06-27
OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA Read more about OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA Patent Cooperation TreatyPCT/US2017/030174Filed on 2017-04-28
Cannabinoid Receptor Mediating Compounds Read more about Cannabinoid Receptor Mediating Compounds Patent Cooperation TreatyPCT/US2017/020250Filed on 2017-03-01
N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT Read more about N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT European Patent16196935.7Filed on 2008-05-30
Methods For Treating Leukemia And Disorders Mediated By CBFBETA And RUNX1 Proteins Read more about Methods For Treating Leukemia And Disorders Mediated By CBFBETA And RUNX1 Proteins United Kingdom12710636.7Filed on 2012-03-15
Methods For Treating Leukemia And Disorders Mediated By CBFBETA And RUNX1 Proteins Read more about Methods For Treating Leukemia And Disorders Mediated By CBFBETA And RUNX1 Proteins Germany12710636.7Filed on 2012-03-15
Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lamin A (LMNA) Read more about Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lamin A (LMNA) US Patent 9,833,468Filed on 2016-03-29
N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT Read more about N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT Japan2016-159061Filed on 2016-08-15